6 June 2016 · This updated Q&A aims to explain controlled drug legislation relevant to primary care dental practice. Includes prescribing for NHS and private patients, ordering/requisitioning, storage and…
10 October 2019 · A joint statement from the Neonatal and Paediatric Pharmacy Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)
28 September 2020 · Consensus views of the Pharmaceutical Market Support Group and the UK Clinical Pharmacists Association: Neurosciences Group on the safety and appropriateness of switching between brand…
20 January 2022 · Levothyroxine is the standard of care for treating hypothyroidism. Desiccated or natural thyroid extracts (DTE) are not routinely recommended.
27 March 2022 · Prescribing medicines by generic name is generally preferred but there are some circumstances when brand-name prescribing is warranted.
27 March 2022 · Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
12 May 2022 · Doxazosin XL tablets should not routinely be prescribed. Guidance is provided on switching doxazosin XL tablets to standard release tablets.
13 June 2022 · Guidance to help you ensure your patients with Parkinson’s Disease are able to get the most from their medicines if they develop swallowing difficulties